Cargando…

AIDS recombinant vaccine; recombinant HIV virus core protein cloning in vaccinia virus vector

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 1991
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131345/ http://dx.doi.org/10.1016/0264-410X(91)90324-Y

Ejemplares similares

Vaccinia Virus Recombinants: Expression Vectors and Potential Vaccines
por: MACKETT, M.
Publicado: (1994)

Chapter 7 Use of Recombinant Vaccinia Virus Vectors for Cell Biology
por: Weisz, Ora A., et al.
Publicado: (1994)

Generation of Recombinant Coronaviruses Using Vaccinia Virus as the Cloning Vector and Stable Cell Lines Containing Coronaviral Replicon RNAs
por: Eriksson, Klara Kristin, et al.
Publicado: (2007)

New protein comprising at least one hepatitis A virus epitope; capsid protein expression in vaccinia virus vector for use as recombinant vaccine
Publicado: (1992)

Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines
por: Chin’ombe, Nyasha, et al.
Publicado: (2013)

Live-Cell Imaging of Vaccinia Virus Recombination
por: Paszkowski, Patrick, et al.
Publicado: (2016)

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
por: Clarke, David K., et al.
Publicado: (2006)

Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
por: Czub, Markus, et al.
Publicado: (2005)

Generation of recombinant vaccinia virus and analysis of virus-induced cell death
por: Liu, Zhijun, et al.
Publicado: (2021)

Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
por: Cottingham, Matthew G., et al.
Publicado: (2008)

MHV S peplomer protein expressed by a recombinant vaccinia virus vector exhibits IgG Fc-receptor activity
por: Oleszak, Emilia L., et al.
Publicado: (1992)

Herpes virus recombinant pox virus recombinant vaccine; recombinant vaccinia virus, canary-pox virus, fowl-pox virus construction by insertion of glycoprotein gene from foreign herpes virus, pseudorabies virus, Epstein-Barr virus or cytomegalovirus
Publicado: (1991)

Antigen Gene Transfer to Human Plasmacytoid Dendritic Cells Using Recombinant Adenovirus and Vaccinia Virus Vectors
por: Bontkes, Hetty J., et al.
Publicado: (2005)

Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice
por: Bohnen, C, et al.
Publicado: (2013)

Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses
por: Holechek, Susan A., et al.
Publicado: (2013)

Expression and cellular localisation of porcine transmissible gastroenteritis virus N and M proteins by recombinant vaccinia viruses
por: Pulford, David J., et al.
Publicado: (1991)

Intracellular processing of the porcine coronavirus transmissible gastroenteritis virus spike protein expressed by recombinant vaccinia virus
por: Pulford, David J., et al.
Publicado: (1991)

Complex virus promoter; complex pox virus promoter construct; recombinant vaccinia virus construction
Publicado: (1991)

Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
por: Cottingham, Matthew G., et al.
Publicado: (2011)

SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus
por: Kitabatake, Masahiro, et al.
Publicado: (2007)

Enzymatic processing of replication and recombination intermediates by the vaccinia virus DNA polymerase
por: Hamilton, Michael D., et al.
Publicado: (2005)

Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
por: Liu, Liqiong, et al.
Publicado: (2022)

Malaria vaccine peptide Plasmodium falciparum circumsporozoite protein gene cloning in vaccinia virus
Publicado: (1989)

Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats
por: Russell, Marsha S., et al.
Publicado: (2021)

A Human Multi-Epitope Recombinant Vaccinia Virus as a Universal T Cell Vaccine Candidate against Influenza Virus
por: Goodman, Alan G., et al.
Publicado: (2011)

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development
Publicado: (1992)

Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma
por: Vasileva, Natalia, et al.
Publicado: (2021)

Reverse Genetics of SARS-Related Coronavirus Using Vaccinia Virus-Based Recombination
por: van den Worm, Sjoerd H. E., et al.
Publicado: (2012)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens
por: Vennema, Harry, et al.
Publicado: (1991)

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer
por: Boursnell, M.E.G., et al.
Publicado: (1996)

Non-infective structural particle preparation containing flavivirus surface antigen protein; Japanese-encephalitis virus cDNA gene cloning in dengue virus-2-preinfected cell with a vaccinia virus vector and use of a non-infective structural particle as recombinant vaccine
Publicado: (1994)

A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease
por: Zhu, Wenjun, et al.
Publicado: (2022)

Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy
por: Vigil, Adam, et al.
Publicado: (2008)

Immunization with a Recombinant Vaccinia Virus That Encodes Nonstructural Proteins of the Hepatitis C Virus Suppresses Viral Protein Levels in Mouse Liver
por: Sekiguchi, Satoshi, et al.
Publicado: (2012)

Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization
por: Noy-Porat, Tal, et al.
Publicado: (2023)

An MVA Vector Expressing HIV-1 Envelope under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design
por: Pérez, Patricia, et al.
Publicado: (2019)

Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy
por: Kochneva, Galina, et al.
Publicado: (2016)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
por: Goepfert, P, et al.
Publicado: (2012)

Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells
por: Koval, Olga, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hmjtegp1jc4gb2cd8jqm7rs9ca